Related Experiment Video

Updated: Jun 18, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

[Clinical features and prognosis in 49 patients with Castleman's disease]

Guo-Pan Yu1, Shu-Jie Wang, Jie Shi

  • 1Department of Internal Medicine, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|December 9, 2009
PubMed

Insights

Castleman disease (CD) presents with varied symptoms, requiring histopathology for diagnosis. Surgery offers a good prognosis for unicentric CD (UCD), while multicentric CD (MCD) has a poorer outlook, necessitating new treatments.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Castleman disease (CD) is a rare lymphoproliferative disorder with diverse clinical presentations.
  • Accurate diagnosis and understanding prognosis are crucial for patient management.

Purpose of the Study:

  • To analyze the clinical features and prognosis of Castleman disease (CD).
  • To differentiate outcomes between unicentric CD (UCD) and multicentric CD (MCD).

Main Methods:

  • Retrospective analysis of clinical and pathological data from 49 CD patients.
  • Data collected from Peking Union Medical College Hospital between January 1990 and December 2007.

Main Results:

  • Unicentric CD (UCD) predominantly featured the hyaline vascular type (88.2%).
  • Multicentric CD (MCD) patients were older, with more complications and abnormal lab results compared to UCD.
  • Surgery led to complete remission in UCD patients; MCD showed a 65.2% overall response rate to chemotherapy, with rituximab showing promise.

Conclusions:

  • CD diagnosis relies on histopathology due to nonspecific clinical features.
  • UCD has a favorable prognosis post-surgery, whereas MCD exhibits a poor response to chemotherapy.
  • Improved outcomes for MCD require novel therapeutic strategies and clinical trials.
Abstract

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...